Applied DNA Sciences APDN

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.01 (+5.32%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Applied DNA Sciences (APDN)
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Key Insights

Critical company metrics and information
  • Latest Closing Price

    $0.1314
  • Market Cap

    $7.25 Million
  • Price-Earnings Ratio

    -0.03
  • Total Outstanding Shares

    55.19 Million Shares
  • Total Employees

    48
  • Dividend

    No dividend
  • IPO Date

    October 31, 2001
  • SIC Description

    Services-testing Laboratories
  • Primary Exchange

    NASDAQ
  • Type

    Common Stock
  • Headquarters

    50 health sciences drive, Stony brook, NY, 11790
  • Homepage

    https://www.adnas.com

Historical Stock Splits

If you bought 48,000 shares of APDN before October 29, 2014, you'd have 1 share today.
Execution DateSplit Amount
April 25, 20241-for-20 (Reverse Split)
November 1, 20191-for-40 (Reverse Split)
October 29, 20141-for-60 (Reverse Split)

Cash Flow Statement

January 1, 2024 to December 31, 2024
MetricValue
Net Cash Flow From Financing Activities, Continuing$19.74 Million
Net Cash Flow From Operating Activities$-13.28 Million
Net Cash Flow, Continuing$2.14 Million
Net Cash Flow From Investing Activities, Continuing$-4.32 Million
Net Cash Flow$2.14 Million
Net Cash Flow From Operating Activities, Continuing$-13.28 Million

Income Statement

January 1, 2024 to December 31, 2024
MetricValue
Gross Profit$1.47 Million
Preferred Stock Dividends And Other Adjustments$14.91 Million
Benefits Costs and Expenses$12.36 Million
Income/Loss From Continuing Operations Before Tax$-8.63 Million
Net Income/Loss Available To Common Stockholders, Basic$-23.59 Million
Basic Average Shares$38.54 Million

Comprehensive Income

January 1, 2024 to December 31, 2024
MetricValue
Comprehensive Income/Loss$-8.63 Million
Comprehensive Income/Loss Attributable To Parent$-8.63 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Other Comprehensive Income/Loss$0

Balance Sheet

January 1, 2024 to December 31, 2024
MetricValue
Intangible Assets$2.70 Million
Noncurrent Liabilities$1.03 Million
Accounts Payable$1.23 Million
Current Liabilities$2.39 Million
Other Current Liabilities$1.15 Million
Equity$12.55 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about APDN from trusted financial sources